# Maya H Buch

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/maya-h-buch/

## Facts

| Field | Value |
| --- | --- |
| Citations | 26,683 |
| Field | Rheumatoid Arthritis Research and Therapies |
| h-index | 69 |
| i10-index | 181 |
| Last Known Institution | Manchester Academic Health Science Centre |
| OpenAlex ID | https://openalex.org/A5042417820 |
| ORCID iD | https://orcid.org/0000-0002-8962-5642 |
| Works | 464 |

## Researcher papers

- [EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic-2/)
- [EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic-3/)
- [\nEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.](https://scholariq.org/papers/neular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic/)
- [Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial](https://scholariq.org/papers/rituximab-versus-tocilizumab-in-anti-tnf-inadequate-responder-patients-with/)
- [Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial](https://scholariq.org/papers/abatacept-in-individuals-at-high-risk-of-rheumatoid-arthritis-apippra-a/)

## Researcher topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Autoimmune and Inflammatory Disorders Research](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders-research/)

## Researcher university

- [Manchester Academic Health Science Centre](https://scholariq.org/institutions/manchester-academic-health-science-centre/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.